These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38024694)

  • 21. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
    Vilar S; Karpiak J; Berk B; Costanzi S
    J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation.
    Daga PR; Zaveri NT
    Proteins; 2012 Aug; 80(8):1948-61. PubMed ID: 22489047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and dynamics of DRD4 bound to an agonist and an antagonist using in silico approaches.
    Jatana N; Thukral L; Latha N
    Proteins; 2015 May; 83(5):867-80. PubMed ID: 25371112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conserved Mechanism of Conformational Stability and Dynamics in G-Protein-Coupled Receptors.
    Bhattacharya S; Salomon-Ferrer R; Lee S; Vaidehi N
    J Chem Theory Comput; 2016 Nov; 12(11):5575-5584. PubMed ID: 27709935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors.
    Dutta S; Selvam B; Das A; Shukla D
    J Biol Chem; 2022 Apr; 298(4):101764. PubMed ID: 35227761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Determinants for Ligand Binding at Serotonin 5-HT
    Córdova-Sintjago T; Sakhuja R; Kondabolu K; Canal CE; Booth RG
    Int J Quantum Chem; 2012 Dec; 112(24):3807-3814. PubMed ID: 23913978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
    Kim SK; Gao ZG; Van Rompaey P; Gross AS; Chen A; Van Calenbergh S; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4847-59. PubMed ID: 14584936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.
    Zhu BT
    J Theor Biol; 1996 Aug; 181(3):273-91. PubMed ID: 8869127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
    Jacobson KA; Gao ZG; Paoletta S; Kiselev E; Chakraborty S; Jayasekara PS; Balasubramanian R; Tosh DK
    Comput Struct Biotechnol J; 2015; 13():286-98. PubMed ID: 25973142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domain coupling in GPCRs: the engine for induced conformational changes.
    Unal H; Karnik SS
    Trends Pharmacol Sci; 2012 Feb; 33(2):79-88. PubMed ID: 22037017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
    Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
    Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-Dependent Modulation of the Dynamics of Intracellular Loops Dictates Functional Selectivity of 5-HT
    Mozumder S; Bej A; Sengupta J
    J Chem Inf Model; 2022 May; 62(10):2522-2537. PubMed ID: 35324173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations.
    Uba AI; Scorese N; Dean E; Liu H; Wu C
    ACS Chem Neurosci; 2021 May; 12(9):1674-1687. PubMed ID: 33860667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
    Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
    Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-Induced Conformational Dynamics of A Tyramine Receptor from Sitophilus oryzae.
    Braza MKE; Gazmen JDN; Yu ET; Nellas RB
    Sci Rep; 2019 Nov; 9(1):16275. PubMed ID: 31700013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.
    Seidel L; Zarzycka B; Zaidi SA; Katritch V; Coin I
    Elife; 2017 Aug; 6():. PubMed ID: 28771403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.